Share
1,246 Posts.
lightbulb Created with Sketch. 2461
clock Created with Sketch. 28/06/23
11:29
Share
Originally posted by CatalystDriven:
↑
A brutal announcement, although like many have said above its not all lost, with $23M in the bank and just ~$1M annual overheads and a couple M coming back in R&D refunds, they can tread water here for 6 months and find their way through an accelerated trial. Whether that's for a $700M EU market rather than a $1B market with other drugs like Ozempic out there, that is yet to be seen. Add TBI afterwards for a leveraged exit value upon IIH success Phase III, they could still sell for a few hundred million to a company already manufacturing similar GLP products with clear acquisition synergies.
Expand
It’s extremely poor to throw this to the market a couple of days after they put out a PS announcement on TBI.
